Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
Go back to Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak| Regeneron (NASDAQ: REGN) | Delayed: 618.03 +5.53 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $612.50 | 52 Week High | $592.36 | |||
| Open | $607.92 | 52 Week Low | $325.35 | |||
| Day High | $621.79 | P/E | 162.21 | |||
| Day Low | $607.92 | EPS | $3.81 | |||
| Volume | 1,268,725 | |||||

